{
    "nctId": "NCT00300508",
    "briefTitle": "3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer",
    "officialTitle": "A Randomized, Open, Comparative Multicentre Trial of 3 Years Anastrozole Treatment vs. 3 Years no Treatment in Postmenopausal Patients With Breast Cancer Who Have Completed 5 Years Adjuvant Hormone Therapy.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 856,
    "primaryOutcomeMeasure": "Recurrence-free and overall survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* No disease recurrence at time of randomization,\n* patients with breast cancer after surgery,\n* 5 years (+/- 12 months) of prior endocrine therapy\n\nExclusion Criteria:\n\n* Premenopausal patients,\n* unknown or negative receptor status,\n* Secondary malignant tumor",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}